ArticlePredictive Value of CD229, CD319 and c-Maf Overexpression for Treatment Response in Multiple Myeloma Patients
ArticlePredictive Value of CD229, CD319 and c-Maf Overexpression for Treatment Response in Multiple Myeloma Patients
ArticleRole of CD319 Expression as A Diagnostic and Prognostic Marker in Plasma Cell Myeloma Patients
ArticleRole of CD319 Expression as A Diagnostic and Prognostic Marker in Plasma Cell Myeloma Patients
ArticleThe role of CD58 and CD38 in evaluation of minimal residual disease in childhood B-acute lymphoblastic leukemia
ArticleThe role of CD58 and CD38 in evaluation of minimal residual disease in childhood B-acute lymphoblastic leukemia
ArticleClinical Significance of Cyclin D1 Expression on Trephine Bone Marrow Biopsies in Plasma Cell Myeloma Patients an Egyptian Study
ArticleClinical Significance of Cyclin D1 Expression on Trephine Bone Marrow Biopsies in Plasma Cell Myeloma Patients an Egyptian Study
ArticleEvaluation of t(14;18)(q32;q21) and BCL2 protein and their prognostic role in follicular lymphoma
ArticleEvaluation of t(14;18)(q32;q21) and BCL2 protein and their prognostic role in follicular lymphoma
ArticleInterleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma
ArticleInterleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma